Aclaris Therapeutics ACRS Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$69.66M+46.5% | -$64.92M+50.8% | -$141.68M-283% | -$134.65M-129% | -$130.21M-68.5% | ||
| $428K-38.2% | $454K-43.7% | $495K-44.5% | $564K-39.5% | $692K-23.8% | ||
| $12.05M-2.1% | $12.38M+14.1% | $12.32M+33.0% | $12.46M+2.1% | $12.3M-22.3% | ||
| -$52.21M— | -$47.11M— | -$42.92M— | —— | —— | ||
| $81K— | $111K— | —— | —— | —— | ||
| -$1.69M+97.5% | $48.37M+169% | -$50.73M-291% | -$61.76M-210% | -$67.48M— | ||
| $52.19M-29.8% | -$5.86M-108% | $71.25M+1,424,940% | $74.32M— | $74.32M— | ||
| —— | —— | —— | —— | -$5.48M— | ||
| -$52.29M— | -$47.22M— | -$43.01M— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Aclaris Therapeutics generate?
- Aclaris Therapeutics (ACRS) generated -$52.2M in operating cash flow over the trailing twelve months.
- What is Aclaris Therapeutics's free cash flow?
- After $81.0K of capital expenditures, Aclaris Therapeutics's free cash flow was -$52.3M over the trailing twelve months, up 5.4% year over year.
- Where does Aclaris Therapeutics's cash flow data come from?
- Every line is extracted from Aclaris Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
